Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Air Lease Pref A | AL-A | Nov 22, 2024 | 25.18 | 0.00 |
Air Products And Chemicals | APD | Nov 22, 2024 | 331.83 | +0.90 |
Air T | AIRTP | Nov 22, 2024 | 17.40 | +0.29 |
Air T | AIRT | Nov 22, 2024 | 19.39 | +5.84 |
Air Transport Services Group | ATSG | Nov 22, 2024 | 21.96 | 0.00 |
Airbnb A | ABNB | Nov 22, 2024 | 137.34 | +3.06 |
Airgain | AIRG | Nov 22, 2024 | 8.95 | +4.31 |
AirJoule Technologies A | AIRJ | Nov 22, 2024 | 7.56 | -4.79 |
AirNet Technology ADR | ANTE | Nov 22, 2024 | 0.53 | +6.97 |
AirSculpt Technologies | AIRS | Nov 22, 2024 | 7.00 | +3.24 |
Airship AI A | AISP | Nov 22, 2024 | 2.44 | 0.00 |
AIX ADR | AIFU | Nov 22, 2024 | 1.26 | 0.00 |
Akamai Technologies | AKAM | Nov 22, 2024 | 92.90 | +2.00 |
Akanda | AKAN | Nov 22, 2024 | 1.36 | +1.49 |
Akari Therapeutics ADR | AKTX | Nov 22, 2024 | 1.30 | +4.84 |
Akebia Therapeutics | AKBA | Nov 22, 2024 | 1.88 | +3.30 |
Akero Therapeutics | AKRO | Nov 22, 2024 | 32.73 | +4.90 |
Akoustis Technologies | AKTS | Nov 22, 2024 | 0.10 | -3.64 |
Akoya BioSciences | AKYA | Nov 22, 2024 | 2.11 | -0.47 |
Akso Health ADR | AHG | Nov 22, 2024 | 0.88 | +0.00 |
Alamo Group | ALG | Nov 22, 2024 | 198.10 | +0.89 |
Alamos Gold | AGI | Nov 22, 2024 | 18.87 | +0.05 |
Alarm.com | ALRM | Nov 22, 2024 | 62.32 | +2.53 |
Alarum Technologies ADR | ALAR | Nov 22, 2024 | 15.20 | +14.37 |
Alaska Air Group | ALK | Nov 22, 2024 | 52.42 | +0.23 |
Alaunos Therapeutics | TCRT | Nov 22, 2024 | 2.39 | +3.02 |
Albany International | AIN | Nov 22, 2024 | 84.78 | +2.73 |
Albemarle | ALB | Nov 22, 2024 | 108.38 | -0.55 |
Albemarle ADR A Pref | ALB-A | Nov 22, 2024 | 48.68 | -0.88 |
Albertsons Companies A | ACI | Nov 22, 2024 | 19.37 | +1.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.